Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus
Clinical trial NCT02683746 · COMPLETED
Trial details
- NCT number
- NCT02683746
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-16
- Primary completion
- 2017-04-03
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.